SEATTLE, Wash. and VANCOUVER, British Columbia, March 5, 2019 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will report its fourth quarter and year-end 2018 financial results on Thursday, March 14, 2019. Company management will host a conference call and live webcast at 4:30pm Eastern Time to provide an overview of financial results, the clinical development program, and a general corporate update.
To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 2057479. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.
(415) 375-3340 ext. 4